Morgan Stanley Talis Biomedical Corp Transaction History

Morgan Stanley

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.44 - $0.54 $440 - $540	1,000 Added 1.64%	61,857 $29,000
Q1 2023 May 15, 2023	BUY	$0.48 - $0.64 $605 - $807	1,262 Added 2.12%	60,857 $29,000
Q4 2022 Feb 14, 2023	SELL	$0.45 - $11.67 $8,901 - $230,844	-19,781 Reduced 24.92%	59,595 $26,000
Q3 2022 Nov 14, 2022	SELL	$0.7 - $10.79 $64,593 - $995,658	-92,276 Reduced 53.76%	79,376 $54,000
Q2 2022 Oct 27, 2022	BUY	$0.81 - $1.44 $17,297 - $30,751	21,355 Added 14.21%	171,652 $139,000
Q2 2022 Aug 15, 2022	BUY	$0.81 - $1.44 $17,297 - $30,751	21,355 Added 14.21%	171,652 $139,000
Q1 2022 Oct 27, 2022	SELL	$1.3 - $4.19 $27,761 - $89,477	-21,355 Reduced 12.44%	150,297 $212,000
Q1 2022 May 13, 2022	SELL	$1.3 - $4.19 $33,848 - $109,095	-26,037 Reduced 14.77%	150,297 $212,000
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.17 $526,846 - $853,187	-138,280 Reduced 43.95%	176,334 $708,000
Q3 2021 Nov 15, 2021	BUY	$6.02 - $12.46 $1.89 Million - $3.92 Million	314,614 New	314,614 $1.97 Million

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $42.6M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.